Clinical Trials Directory

Trials / Completed

CompletedNCT00941525

Central Corneal Thickness and 24-hour Fluctuation of Intraocular Pressure

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
174 (actual)
Sponsor
Aristotle University Of Thessaloniki · Academic / Other
Sex
All
Age
50 Years – 85 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to determine whether 24-hour fluctuation of intraocular pressure (IOP) is associated with central corneal thickness (CCT) in subjects with ocular hypertension or open angle glaucoma and in age-matched controls. Also to evaluate whether mean IOP reduction as a response to latanoprost (0.005% Xalatan) is associated with CCT, after a 4-weeks period of treatment. Also, to evaluate whether 24-hour fluctuation of IOP is associated with corneal hysteresis (CH) measured by Ocular Response Analyzer (ORA).

Conditions

Interventions

TypeNameDescription
DRUGLatanoprost1 eyedrop of latanoprost (0.005%) dosed once a day at 8:00pm for a 4-weeks period

Timeline

Start date
2009-09-01
Primary completion
2014-07-01
Completion
2014-07-01
First posted
2009-07-17
Last updated
2015-07-07

Locations

1 site across 1 country: Greece

Source: ClinicalTrials.gov record NCT00941525. Inclusion in this directory is not an endorsement.

Central Corneal Thickness and 24-hour Fluctuation of Intraocular Pressure (NCT00941525) · Clinical Trials Directory